Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18287| Title: | Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC? | Austin Authors: | Klevansky, Myron ;John, Thomas | Affiliation: | Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Jun-2018 | Publication information: | Journal of thoracic disease 2018; 10(Suppl 17): S1986-S1988 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/18287 | DOI: | 10.21037/jtd.2018.04.156 | Journal: | Journal of thoracic disease | PubMed URL: | 30023098 | ISSN: | 2072-1439 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.